Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Coenzyme Q and vitamin E interactions.

× No keyword cloud information.

11 in total

1. 4-Nitrobenzoate inhibits coenzyme Q biosynthesis in mammalian cell cultures.

Authors: Ulrika Forsman; Mats Sjöberg; Mikael Turunen; Pavel J Sindelar
Journal: Nat Chem Biol Date: 2010-06-06 Impact factor: 15.040

2. Coenzyme Q₁₀ and Pyridoxal Phosphate Deficiency Is a Common Feature in Mucopolysaccharidosis Type III.

Authors: Dèlia Yubero; Raquel Montero; Mar O'Callaghan; Mercè Pineda; Silvia Meavilla; Veronica Delgadillo; Cristina Sierra; Laura Altimira; Plácido Navas; Simon Pope; Marcus Oppenheim; Viruna Neergheen; Arunabha Ghosh; Phillipa Mills; Peter Clayton; Emma Footitt; Maureen Cleary; Iain Hargreaves; Simon A Jones; Simon Heales; Rafael Artuch
Journal: JIMD Rep Date: 2015-07-24

3. Coenzyme Q10: is there a clinical role and a case for measurement?

Authors: Sarah L Molyneux; Joanna M Young; Christopher M Florkowski; Michael Lever; Peter M George
Journal: Clin Biochem Rev Date: 2008-05

Review 4. Coenzyme Q, oxidative stress and aging.

Authors: Rajindar S Sohal; Michael J Forster
Journal: Mitochondrion Date: 2007-03-30 Impact factor: 4.160

Review 5. The cold but not hard fats in ectotherms: consequences of lipid restructuring on susceptibility of biological membranes to peroxidation, a review.

Authors: Elizabeth L Crockett
Journal: J Comp Physiol B Date: 2008-05-28 Impact factor: 2.200

Review 6. Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots.

Authors: Shao-Hua Yang; Wenjun Li; Nathalie Sumien; Michael Forster; James W Simpkins; Ran Liu
Journal: Prog Neurobiol Date: 2015-11-18 Impact factor: 11.685

Coenzyme Q and vitamin E interactions.

1. 4-Nitrobenzoate inhibits coenzyme Q biosynthesis in mammalian cell cultures.

2. Coenzyme Q₁₀ and Pyridoxal Phosphate Deficiency Is a Common Feature in Mucopolysaccharidosis Type III.

3. Coenzyme Q10: is there a clinical role and a case for measurement?

Review 4. Coenzyme Q, oxidative stress and aging.

Review 5. The cold but not hard fats in ectotherms: consequences of lipid restructuring on susceptibility of biological membranes to peroxidation, a review.

Review 6. Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots.

Review 7. Coenzyme Q10 for the treatment of heart failure: a review of the literature.

8. Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension.

Review 9. The Use of Coenzyme Q10 in Cardiovascular Diseases.

10. The submitochondrial distribution of ubiquinone affects respiration in long-lived Mclk1+/- mice.

Coenzyme Q and vitamin E interactions.

1. 4-Nitrobenzoate inhibits coenzyme Q biosynthesis in mammalian cell cultures.

2. Coenzyme Q10 and Pyridoxal Phosphate Deficiency Is a Common Feature in Mucopolysaccharidosis Type III.

3. Coenzyme Q10: is there a clinical role and a case for measurement?

Review 4. Coenzyme Q, oxidative stress and aging.

Review 5. The cold but not hard fats in ectotherms: consequences of lipid restructuring on susceptibility of biological membranes to peroxidation, a review.

Review 6. Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots.

Review 7. Coenzyme Q10 for the treatment of heart failure: a review of the literature.

8. Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension.

Review 9. The Use of Coenzyme Q10 in Cardiovascular Diseases.

10. The submitochondrial distribution of ubiquinone affects respiration in long-lived Mclk1+/- mice.

2. Coenzyme Q₁₀ and Pyridoxal Phosphate Deficiency Is a Common Feature in Mucopolysaccharidosis Type III.